Lord, Abbett & Co’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-139,618
| Closed | -$23.6M | – | 603 |
|
2023
Q3 | $23.6M | Sell |
139,618
-434,988
| -76% | -$73.6M | 0.09% | 300 |
|
2023
Q2 | $125M | Buy |
574,606
+83,464
| +17% | +$18.1M | 0.43% | 56 |
|
2023
Q1 | $89.2M | Sell |
491,142
-57,179
| -10% | -$10.4M | 0.32% | 88 |
|
2022
Q4 | $108M | Sell |
548,321
-146,457
| -21% | -$28.8M | 0.39% | 69 |
|
2022
Q3 | $156M | Buy |
694,778
+412,548
| +146% | +$92.8M | 0.57% | 39 |
|
2022
Q2 | $35.7M | Sell |
282,230
-87,315
| -24% | -$11M | 0.13% | 222 |
|
2022
Q1 | $46.9M | Buy |
369,545
+127,840
| +53% | +$16.2M | 0.12% | 231 |
|
2021
Q4 | $31.7M | Sell |
241,705
-69,911
| -22% | -$9.16M | 0.07% | 329 |
|
2021
Q3 | $38.1M | Sell |
311,616
-57,030
| -15% | -$6.98M | 0.09% | 323 |
|
2021
Q2 | $42M | Buy |
368,646
+55,085
| +18% | +$6.28M | 0.1% | 287 |
|
2021
Q1 | $37.7M | Buy |
313,561
+37,834
| +14% | +$4.55M | 0.1% | 310 |
|
2020
Q4 | $28M | Buy |
275,727
+6,648
| +2% | +$675K | 0.07% | 360 |
|
2020
Q3 | $20.8M | Buy |
269,079
+7,535
| +3% | +$583K | 0.07% | 372 |
|
2020
Q2 | $29.2M | Sell |
261,544
-52,031
| -17% | -$5.8M | 0.1% | 305 |
|
2020
Q1 | $22.6M | Buy |
313,575
+120,612
| +63% | +$8.68M | 0.1% | 302 |
|
2019
Q4 | $14.5M | Buy |
+192,963
| New | +$14.5M | 0.05% | 451 |
|